Top 10 Companies in the Global Omega‑7 Market (2026): Market Leaders Driving Nutraceutical Innovation

MARKET INSIGHTS

Global Omega‑7 market was valued at USD 125.4 million in 2025 and is projected to reach USD 210.8 million by 2034, growing at a CAGR of 7.3% during the forecast period (2025‑2034). This growth is driven by increasing consumer awareness of Omega‑7’s health benefits and rising demand for nutraceuticals.

Omega‑7 (palmitoleic acid) is a monounsaturated fatty acid found in select natural sources like sea buckthorn berries, macadamia nuts, and anchovy oil. Unlike Omega‑3 or Omega‑6, it plays a unique role in supporting cardiovascular health, skin hydration, and metabolic functions. The compound exists in two primary forms: fish‑derived (marine sources) and plant‑derived (nut sources), with the latter gaining traction due to vegan dietary trends.

While the market shows promising growth, challenges like high production costs and limited raw material availability persist. However, recent innovations in extraction technologies and strategic partnerships among key players—such as KD Pharma Group’s 2023 expansion of sea buckthorn processing facilities—are creating new opportunities. North America currently dominates consumption, but Asia‑Pacific is emerging as the fastest‑growing region due to increasing disposable incomes and health consciousness.

Global Omega‑7 Market – View in Detailed Research Report

MARKET DYNAMICS

MARKET DRIVERS

Rising Awareness of Omega‑7 Benefits in Cardiovascular Health to Accelerate Market Growth

Global Omega‑7 market is witnessing significant growth driven by increasing consumer awareness about its cardiovascular benefits. Numerous clinical studies have validated Omega‑7’s ability to support heart health by maintaining healthy cholesterol levels and reducing arterial inflammation. With cardiovascular diseases remaining the leading cause of mortality worldwide, representing approximately 32% of all global deaths, demand for preventive nutraceuticals like Omega‑7 continues to rise. Manufacturers are responding by expanding product portfolios with targeted cardiovascular formulations, often emphasizing the palmitoleic acid content which is the primary fatty acid in Omega‑7 supplements.

Expansion in Functional Food and Beverage Applications to Fuel Demand

The functional food and beverage industry’s rapid expansion presents substantial opportunities for Omega‑7 integration. Market penetration is increasing as formulators recognize Omega‑7’s stability in various delivery systems, from gummies to ready‑to‑drink beverages. Compared to traditional softgel capsules, these innovative formats significantly broaden consumer accessibility and appeal to younger demographics. Notably, the global functional food market is projected to maintain a compound annual growth rate of over 6%, creating a robust ecosystem for innovative ingredients like Omega‑7 that can demonstrate clear physiological benefits.

Recent product launches showcase this trend, with several mainstream brands introducing Omega‑7 fortified products across multiple categories. A leading manufacturer recently debuted an Omega‑7 enriched kombucha line, combining gut health benefits with cardiovascular support in a trendy fermented format. Furthermore, these developments coincide with rising consumer preference for science‑backed functional ingredients, positioning Omega‑7 favorably within the broader nutraceutical landscape.

MARKET CHALLENGES

Limited Source Availability and High Production Costs Impede Market Expansion

Despite growing demand, the Omega‑7 market faces substantial challenges regarding raw material sourcing. Unlike more established omega fatty acids, Omega‑7 occurs naturally in limited sources such as sea buckthorn berries and select marine oils, creating supply chain vulnerabilities. Production costs remain elevated due to complex extraction processes required to achieve pharmaceutical‑grade purity, with current methodologies yielding relatively low concentrations from source materials. These factors contribute to retail pricing that positions Omega‑7 supplements significantly higher than comparable omega‑3 products, potentially limiting mass market adoption.

Other Challenges

Regulatory Fragmentation

Diverse global regulations concerning health claims and nutraceutical classifications create barriers to international market expansion. While some regions permit cardiovascular support claims with specific qualifying language, others restrict such statements pending further clinical validation.

Consumer Education Gaps

Many potential consumers remain unfamiliar with Omega‑7 benefits versus more widely recognized omega‑3 and omega‑6 fatty acids, requiring substantial marketing investment to build category awareness and justify premium pricing positions adopted by most manufacturers.

MARKET RESTRAINTS

Competition from Substitute Ingredients to Moderate Growth Potential

The Omega‑7 market faces considerable restraint from well‑established alternative ingredients that deliver overlapping health benefits. Omega‑3 fatty acids, particularly EPA and DHA from fish oils, dominate the cardiovascular supplement space with significantly greater consumer awareness and clinical validation. Additionally, emerging plant‑derived alternatives like omega‑9 rich oils present cost‑effective substitutes for certain applications. This competitive landscape creates pressure on Omega‑7 manufacturers to clearly differentiate their value proposition and substantiate superior efficacy claims through targeted clinical research.

Brand loyalty toward established omega formulations presents another hurdle, as many consumers demonstrate reluctance to switch from familiar products without compelling evidence of Omega‑7’s comparative advantages. Manufacturers must navigate these challenges while addressing pricing disparities that currently favor more commoditized alternatives.

MARKET OPPORTUNITIES

Innovative Applications in Dermatology and Dry Eye Management to Unlock New Growth Avenues

Emerging research highlighting Omega‑7’s dermatological benefits is creating exciting opportunities in the $140 billion global skincare market. Preliminary studies demonstrate palmitoleic acid’s effectiveness in supporting skin barrier function and hydration, prompting several prestige skincare brands to explore Omega‑7 incorporation. Simultaneously, the nutraceutical industry is witnessing growing interest in Omega‑7 for managing dry eye syndrome following positive clinical outcomes measuring tear film improvement.

These specialized applications command premium pricing potential and attract partnerships with medical professionals seeking evidence‑based adjunct therapies. Forward‑looking companies are investing in targeted clinical trials to strengthen these emerging value propositions and differentiate from general omega supplement positioning.

MARKET TRENDS

Growing Demand in Personal Care and Nutraceuticals to Drive Market Expansion

Global Omega‑7 market is experiencing significant growth, primarily driven by increasing awareness of its health benefits and expanding applications in personal care and nutraceutical industries. Omega‑7 fatty acids, primarily derived from sources such as fish oil and sea buckthorn berries, play a crucial role in metabolic health, cardiovascular wellness, and skin rejuvenation. The rising prevalence of lifestyle diseases, coupled with consumer preference for natural ingredient‑based supplements, is accelerating demand. Projections indicate the market could reach **$300 million by 2026**, fueled by a **CAGR of 6.8%** from 2022 to 2026. Innovations in encapsulation technologies to enhance bioavailability and stability are further supporting product adoption in functional foods and dietary supplements.

Other Trends

Rising Emphasis on Sustainable Sourcing

Sustainability is emerging as a key trend influencing production and procurement strategies in the Omega‑7 market. Manufacturers are prioritizing ethically sourced raw materials, particularly from wild‑caught fish and organic berry farms, to cater to environmentally conscious consumers. Regulatory frameworks promoting marine conservation and sustainable fishing practices are reshaping supply chains, with leading brands investing in traceability technologies to assure product integrity. Collaborations with aquaculture farms for algal‑derived Omega‑7 are also gaining traction, offering a scalable and eco‑friendly alternative to traditional sources.

Expansion in Personalized Nutrition and Healthcare

Personalized nutrition is transforming the Omega‑7 landscape, with growing demand for tailored formulations targeting metabolic syndrome, dry eye syndrome, and dermatological conditions. The nutraceutical sector is leveraging clinical research that underscores Omega‑7’s efficacy in reducing inflammation and improving lipid profiles. Emerging applications in sports nutrition, particularly for joint health, are broadening the consumer base. Clinics and wellness centers are increasingly incorporating Omega‑7 into therapeutic regimens, with studies highlighting its potential to enhance insulin sensitivity and support weight management. North America and Europe currently dominate the market, but Asia‑Pacific is poised for rapid growth due to rising disposable incomes and preventive healthcare awareness.

COMPETITIVE LANDSCAPE

Key Industry Players

Innovation and Strategic Partnerships Drive Growth in the Omega‑7 Market

Global Omega‑7 market exhibits a fragmented competitive landscape, with specialized companies competing alongside diversified nutrition and pharmaceutical players. Tersus Life Sciences LLC has emerged as a market leader through its patented technology for producing highly concentrated Omega‑7 from sea buckthorn berries, holding approximately 25‑30% market share in the plant‑derived Omega‑7 segment as of 2024.

Meanwhile, KD Pharma Group and AlaskOmega dominate the marine‑sourced Omega‑7 segment, leveraging their expertise in fish oil purification technologies. These companies have invested heavily in molecular distillation processes to enhance product purity, responding to growing demand from pharmaceutical applications.

The market has seen increased competition from regional players expanding globally. Aromtech Oy Ltd., originally focused on Nordic markets, recently entered North America through a distribution partnership, while Europharma strengthened its European presence by acquiring smaller specialty manufacturers. Such strategic moves are reshaping competitive dynamics across geographic markets.

Product innovation remains the primary battleground, with companies differentiating through delivery formats (softgels, powders, emulsions) and combination products. Organic Technologies recently launched a breakthrough Omega‑7 + Vitamin E complex, specifically targeting the skincare segment which is projected to grow at 8‑10% CAGR through 2028.

List of Key Omega‑7 Companies Profiled

Tersus Life Sciences LLC (Canada)
Aromtech Oy Ltd. (Finland)
Organic Technologies (U.S.)
Europharma (U.S.)
AlaskOmega (U.S.)
KD Pharma Group (Germany)
Natures Crops International (Canada)
SeabuckWonders (U.S.)
Bioriginal Food & Science Corp (Canada)

Segment Analysis:

By Type

Fish Omega‑7 Segment Leads the Market Owing to Higher Bioavailability and Wider Application Scope

The market is segmented based on type into:

Fish Omega‑7
Nut Omega‑7

By Application

Cardiovascular Health Segment Dominates Due to Rising Prevalence of Heart Diseases

The market is segmented based on application into:

Cardiovascular Health
Sports Nutrition & Joint Health
Personal Care
Dry Eye Conditions
Others

By End User

Pharmaceutical Industry Holds Significant Share Owing to Increased Usage in Drug Formulations

The market is segmented based on end user into:

Pharmaceutical Industry
Nutraceutical Industry
Cosmetic Industry
Research Institutes

By Form

Softgels Lead the Market Due to Convenience and Better Absorption Rates

The market is segmented based on form into:

Softgels
Capsules
Liquids
Powders

Regional Analysis: Global Omega‑7 Market

North America

The North American Omega‑7 market is driven by increasing consumer awareness of the health benefits associated with Omega‑7 fatty acids, particularly in cardiovascular health and personal care applications. The U.S. leads the region, with a strong demand for nutraceuticals and dietary supplements. Regulatory support from the FDA for health claims related to Omega‑7, combined with a well‑established supplement industry, has accelerated market growth. The region is also witnessing a shift toward plant‑based Omega‑7 sources, such as sea buckthorn, as consumers prioritize sustainability. However, high production costs and limited availability of raw materials remain challenges for manufacturers.

Europe

Europe’s Omega‑7 market is characterized by stringent regulatory oversight, particularly under the European Food Safety Authority (EFSA), which ensures product safety and efficacy. The region has a well‑developed nutraceutical sector, with Germany and the UK leading in demand for Omega‑7 supplements for cardiovascular and joint health. The personal care industry is also adopting Omega‑7 for its anti‑aging and skin hydration properties. Sustainability is a key trend, with manufacturers focusing on eco‑friendly extraction methods. Despite these advantages, market growth is somewhat restrained by high competition and strict labeling regulations.

Asia‑Pacific

Asia‑Pacific is the fastest‑growing Omega‑7 market, driven by rising disposable incomes, increasing health awareness, and a booming nutraceutical industry. China and India are the primary contributors, with consumers increasingly adopting Omega‑7 supplements for heart health and diabetes management. The personal care sector is also expanding, with Omega‑7 being incorporated into skincare products. However, price sensitivity and a preference for traditional remedies in some countries may slow market penetration. The region’s vast agricultural resources also present opportunities for plant‑based Omega‑7 production, particularly from macadamia nuts and sea buckthorn.

South America

South America’s Omega‑7 market is in its early stages, with Brazil and Argentina showing the most potential. The region’s growing middle class and increasing health consciousness are driving demand for dietary supplements. However, economic instability and limited regulatory frameworks for nutraceuticals pose challenges. Local manufacturers are exploring indigenous sources of Omega‑7, such as macadamia nuts, to reduce dependency on imports. While the market is small compared to other regions, it offers long‑term growth potential as awareness of Omega‑7 benefits increases.

Middle East & Africa

The Middle East & Africa region is gradually recognizing the benefits of Omega‑7, particularly in the Gulf Cooperation Council (GCC) countries, where demand for premium health supplements is rising. South Africa is also emerging as a key market due to its growing nutraceutical sector. However, limited consumer awareness and economic constraints in other African nations hinder market expansion. The region’s harsh climate and limited agricultural resources make local production challenging, leading to reliance on imports. Despite these challenges, increasing urbanization and healthcare investments are expected to drive future growth.

Report Scope

This report presents a comprehensive analysis of the Global and regional markets for Omega‑7, covering the period from 2025 to 2034. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:

Sales, sales volume, and revenue forecasts
Detailed segmentation by type and application

In addition, the report offers in-depth profiles of key industry players, including:

Company profiles
Product specifications
Production capacity and sales
Revenue, pricing, gross margins
Sales performance

It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.

As part of this research, we surveyed Omega‑7 companies and industry experts. The survey covered various aspects, including:

Revenue and demand trends
Product types and recent developments
Strategic plans and market drivers
Industry challenges, obstacles, and potential risks

FREQUENTLY ASKED QUESTIONS:

What is the current market size of Global Omega‑7 Market?

-> Global Omega‑7 market was valued at USD 125.4 million in 2023 and is expected to reach USD 210.8 million by 2030, growing at a CAGR of 7.3% during the forecast period.

Which key companies operate in Global Omega‑7 Market?

-> Key players include Tersus Life Sciences LLC, Aromtech Oy Ltd., Organic Technologies, Europharma, AlaskOmega, and KD Pharma Group, among others.

What are the key growth drivers?

-> Key growth drivers include rising demand for nutraceuticals, increasing awareness of cardiovascular health benefits, and expanding applications in personal care products.

Which region dominates the market?

-> North America holds the largest market share, while Asia‑Pacific is projected to witness the fastest growth during the forecast period.

What are the emerging trends?

-> Emerging trends include plant‑based omega‑7 formulations, innovative extraction technologies, and growing clinical research on therapeutic applications.